Washing out of lipophilic compounds induces a transient increase in the passive Ca2+ leak in permeabilized A7r5 cells
Section snippets
INTRODUCTION
The immunophilins are a family of proteins that mediate the actions of immunosuppressant drugs like FK506 (tacrolimus) 1., 2., 3.. FK506, a macrocyclic lactone antibiotic and potent immunosuppressive agent, binds to the immunophilin FKBP12. The FK506–FKBP12 complex then inhibits calcineurin, an essential enzyme for T-cell activation [4].
It recently became apparent that FKBP12 also associates with the three different isoforms of the ryanodine receptor (RyR) 5., 6., 7.. This association between
MATERIALS AND METHODS
A7r5 cells, an established cell line derived from embryonic rat aorta, were used between the 7th and the 17th passage after receipt from the American Type Culture Collection (Bethesda, MD, USA). The cells were cultured at 37 °C in a 9% CO2 incubator in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum, 3.8 mM l-glutamine, 0.9% (v/v) non-essential amino acids, 85 IU/ml penicillin and 85 μg/ml streptomycin. The cells were seeded in 12-well dishes (Costar, MA, USA; 4 cm2) at a
RESULTS AND DISCUSSION
Permeabilized monolayers of A7r5 smooth-muscle cells form a useful model system for investigating unidirectional Ca2+ release out of the intracellular stores 15., 16.. Since the passive Ca2+ leak from the internal Ca2+ stores can accurately be determined [12], we have used these cells to measure the effects of FK506 and of other lipophilic compounds on the passive Ca2+ leak. Permeabilized A7r5 cells loaded to steady state with Ca2+ slowly lost their accumulated Ca2+ during incubation in a Ca2+
Acknowledgements
This research was financed by the Interuniversity Poles of Attraction Program—Belgian State, Prime Minister’s Office—Federal Office for Scientific, Technical and Cultural Affairs IUAP P4/23 and by Grant 3.0207.99 of the Foundation for Scientific Research—Flanders. G.B. was supported by the “Vlaams Instituut voor de Bevordering van het Wetenschappelijk-Technologisch Onderzoek in de Industrie (I.W.T.)” and has now a postdoctoral fellowship of the “Onderzoeksraad—K.U.Leuven.” We thank Dr. A.
References (30)
- et al.
Calcineurin is a common target of cyclophilin–cyclosporin A and FKBP–FK506 complexes
Cell
(1991) - et al.
FK506 binding protein associated with the calcium release channel (ryanodine receptor)
J. Biol. Chem.
(1992) - et al.
The calcium release channel of sarcoplasmic reticulum is modulated by FK506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum
J. Biol. Chem.
(1993) - et al.
The conserved sites for the FK506-binding proteins in ryanodine receptors and inositol 1,4,5-trisphosphate receptors are structurally and functionally different
J. Biol. Chem.
(2001) - et al.
Hypotonically induced calcium release from intracellular calcium stores
J. Biol. Chem.
(1996) - et al.
Synergism between hypotonically induced calcium release and fatty acyl-CoA esters induced calcium release from intracellular stores
Cell Calcium
(1997) - et al.
Co-activation of inositol trisphosphate-induced Ca2+ release by cytosolic Ca2+ is loading-dependent
J. Biol. Chem.
(1994) - et al.
Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction
J. Biol. Chem.
(1994) - et al.
Single channel activity of the ryanodine receptor calcium release channel is modulated by FK506
FEBS Lett.
(1994) - et al.
Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux
Cell
(1995)
Rectification of skeletal muscle ryanodine receptor mediated by FK506 binding protein
Biophys. J.
Ryanodine receptor type III (Ry3R) identification in mouse parotid acini. Properties and modulation of []ryanodine-binding sites
J. Biol. Chem.
Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor
Neuron
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Nature
FK506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
Nature
Cited by (8)
Tacrolimus preconditioning of rat liver allografts impacts glutathione homeostasis and early reperfusion injury
2012, Journal of Surgical ResearchCitation Excerpt :Other investigators were able to demonstrate the preservation of microvascular perfusion following liver ischemia and reperfusion [44], and a substantial decrease in free radical production in association with improvement of IRI when tacrolimus is administered before ischemia [18, 45, 46]. Because tacrolimus is a highly lipophilic compound and, therefore, easily crosses the plasma membrane to gain access to intracellular spaces [47], it seemed likely that the primary antioxidative action of tacrolimus takes place within the hepatocytes. This theory was supported by our results, which showed an extraction rate of tacrolimus from the rinse solution via the portal vein of allografts between 88% (50 ng/mL) and 100% (10 ng/mL; Fig. 1), suggesting a nearly complete absorbance of the compound by the cells of the liver.
Calcineurin and intracellular Ca<sup>2+</sup>-release channels: Regulation or association?
2003, Biochemical and Biophysical Research CommunicationsCitation Excerpt :It has been shown that ivermectin and other macrocyclic drugs can directly activate RyRs without the presence of FKBP12 [53]. In addition, washing-out of immunosuppressive drugs induced a transient increase in the Ca2+ efflux from the ER Ca2+ stores in permeabilized A7r5 smooth-muscle cells [54]. As already mentioned above, except for the potential interaction of calcineurin with the IP3R ([9], see 1.2.),
Effects of tacrolimus on ischemia-reperfusion injury
2003, Liver TransplantationThe role of calmodulin for inositol 1,4,5-trisphosphate receptor function
2002, Biochimica et Biophysica Acta - Proteins and ProteomicsCalcineurin inhibitors and rapamycin: Cancer protection or promotion?
2007, Experimental DermatologyPharmacological modulation of sarcoplasmic reticulum function in smooth muscle
2004, Pharmacological Reviews